MedTrace Logo

Effects of MET and MFR on Piriformis Syndrome

NCT07769203 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 72

Last updated 2026-08-17

No results posted yet for this study

Summary

The aim of this study is to comparatively evaluate the effects of two different manual therapy approaches, Muscle Energy Technique (MET) and Myofascial Release Technique (MFR), on pain threshold, muscle activation patterns, and muscle strength in individuals diagnosed with piriformis syndrome.

In this study, the physiological effects of both interventions on the musculoskeletal system will be assessed using objective measurement tools such as an algometer, digital dynamometer, and electromyography (EMG). The study aims to provide evidence-based data regarding the most effective and preferable manual therapy approach in the conservative treatment of piriformis syndrome.

Conditions

  • Piriformis Syndrome

Interventions

PROCEDURE

Muscle Energy Technique

Muscle Energy Technique (MET) will be applied to participants by a trained physiotherapist in addition to conventional physical therapy. The intervention will be performed for 8 weeks, 2 sessions per week, totaling 16 sessions. The technique will include voluntary muscle contractions followed by relaxation and stretching procedures targeting the piriformis muscle.

PROCEDURE

Myofascial Release Technique

Myofascial Release Technique (MFR) will be applied to participants by a trained physiotherapist in addition to conventional physical therapy. The intervention will be performed for 8 weeks, 2 sessions per week, totaling 16 sessions. The technique will involve sustained manual pressure and soft tissue release techniques targeting the piriformis muscle and surrounding fascia.

PROCEDURE

Conventional Physical Therapy

Participants in the control group will receive conventional physical therapy for 8 weeks, 2 sessions per week, totaling 16 sessions.

Sponsors & Collaborators

  • Igdir University

    lead OTHER

Principal Investigators

  • Yavuz Yakut, Prof. Dr. · Hasan Kalyoncu University Faculty of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-08-30
Primary Completion
2026-11-30
Completion
2026-12-31

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07769203 on ClinicalTrials.gov